Biogen Inc. BIIB
NASDAQ · United States · Health Technology
$225.88-1.19 (-0.52%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | 3.60 | 2.94 | +22.5% | $2.74B | +11.2% | +1.1%$205.61→$207.93 |
| Q1 2026 | 2026-04-29 | 3.57 | 2.95 | +21.0% | — | — | +3.2%$183.38→$189.28 |
| Q4 2025 | 2026-02-06 | 1.99 | 1.62 | +22.8% | — | — | +4.6%$185.36→$193.81 |
| Q3 2025 | 2025-10-30 | 4.81 | 3.88 | +24.0% | — | — | +4.3%$147.86→$154.27 |
| Q2 2025 | 2025-07-31 | 5.47 | 3.88 | +41.0% | — | — | — |
| Q1 2025 | 2025-05-01 | 3.02 | 2.95 | +2.4% | — | — | — |
| Q4 2024 | 2025-02-12 | 3.44 | 3.36 | +2.4% | — | — | — |
| Q3 2024 | 2024-10-30 | 4.08 | 3.79 | +7.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.